Addr: Rm 708, Building B, No. 125 Lai Ting South Road, Songjiang District, Shanghai, China.
Tel: +86-21-57680326 Hotline: +86-21-57680965
Postcode: 201615
Enki Biopharma has two production bases in Xiangtan, Hunan and Chengdu, Sichuan.
Hunan Xiangtan production base, founded in 2017, with a total investment of 200 million yuan, covers an area of nearly 60,000 m2, the total construction area of 15,181.63 m2, and the total construction area of the production workshop is about 11,000 m2; The company has nearly 120 employees, including nearly 60% of college degree or above. The core technical team members include 2 doctors, 4 masters and more than 40 R & D, production and engineering technicians with many years of professional experience; The base can be engaged in the process route development and product customization processing of intermediates and APIs from gram to kilogram under the reaction conditions of -100℃ to 300℃, and can produce characteristic pharmaceutical intermediates and APIs from 100 kg to ton. The company obtained the drug production license in October 2022, and passed the registration on-site verification and GMP compliance inspection of the API for the first time in April 2023.